1. Introduction {#sec0005}
===============

Externalizing disorders such as conduct disorder (CD) and attention-deficit hyperactivity disorder (ADHD) are characterized by behaviors including aggressiveness, impulsivity, sensation seeking, and often criminal behavior at older ages ([@bib0025]; [@bib0140]; [@bib0155]). Externalizing disorders are strongly associated with substance use, including tobacco use ([@bib0045]; [@bib0165]; [@bib0040]), and externalizing behaviors or symptoms below a clinical threshold are similarly associated with increased risk of smoking ([@bib0175]). Individuals with externalizing disorders have similar rates of smoking as other psychiatric disorders (∼\>40%), experience higher rates of smoking, earlier onset of smoking, and greater nicotine dependency ([@bib0270]; [@bib0160]; [@bib0210]; [@bib0015]).

Externalizing disorders are associated with deficits in reward function -- reduced sensitivity to favorable stimuli and increased reward sensitivity. ([@bib0315]). For example, ADHD is characterized by abnormal functioning of the striatal dopaminergic system and disruptions in dopaminergic transmission within corticostriatal circuits, resulting in executive functioning deficits ([@bib0235]; [@bib0290]). These individuals display decreased dopamine (DA) tone from below-normal presynaptic activation of DA autoreceptors resulting in exaggerated DA release to salient stimuli ([@bib0235]). In both clinical and preclinical studies, nicotine is shown to stimulate striatal DA release, suggesting nicotine-stimulated DA release may be more rewarding in individuals with ADHD ([@bib0235]; [@bib0075]; [@bib0035]). Therefore, individuals with ADHD may find higher levels of reward reinforcement from initial tobacco use, which may, in turn, facilitate the transition to continued use ([@bib0235]).

Additionally, externalizing disorders are characterized by impulsive behavior (behavior that lacks foresight, evaluation, and inhibitory control). These individuals typically prefer immediate rewards (over possible larger rewards in the future) ([@bib0315]). Therefore, impulsivity may lead individuals to choose rewarding stimuli despite the possibility of negative outcomes. A hypersensitive reward system may predispose individuals to early-onset substance use or mediate the transition from experimental to more frequent/ daily use ([@bib0005]). Animal studies have supported this hypothesis, as rodents divided into 'high-impulsivity' and 'low impulsivity' groups based on attentional tasks show differential response to drug self-administration. High-impulsive displayed more rapid acquisition and higher rates of drug self-administration in response to decreased levels of dopamine D2-receptor binding ([@bib0085]). These findings are mirrored in human PET studies where decreased striatum D2-receptor density is observed in addicted individuals, resulting in increased positive psychological and physiological response to initial drug exposure ([@bib0320], [@bib0325]; [@bib0330]).

Tobacco may also be used for self-medication in individuals with ADHD to alleviate ADHD symptoms through negative reinforcement ([@bib0215]; [@bib0280]). Studies using transdermal nicotine patches alongside stimulant medicine have displayed increased attention capabilities in adult ADHD patients ([@bib0135]). Furthermore, studies using nicotine patches in non-smoking ADHD patients have displayed increases in attention and cognition similar to methylphenidate ([@bib0275]), improved behavioral inhabitation ([@bib0275]) and increased positive affect ([@bib0225]; [@bib0280]; [@bib0235]).

However, the causal nature of this relationship and the direction of causality remain unclear. Evidence from longitudinal studies suggests that externalizing behaviors in children are associated with subsequent early onset tobacco use ([@bib0180]; [@bib0040]; [@bib0080]; [@bib0010]), and while reverse causality is unlikely in this context due to the onset of externalizing disorders in young children (prior to average smoking initiation ∼age 15), residual confounding may still be operating (e.g. via intrauterine tobacco exposure). Experimental studies are typically impossible in substance use research for long-term outcomes for obvious ethical and practical reasons. While we can examine the association between externalizing behaviors and tobacco use in observational studies, these have provided conflicting evidence on the temporal direction of association ([@bib0180]; [@bib0065]; [@bib0040]; [@bib0080]; [@bib0150]). Ultimately, however, conventional epidemiological methods using observational data cannot support a strong causal inference as problems such as selection bias, reverse causation, and residual confounding is inherent in observational data ([@bib0090]). It is therefore important to consider alternative methods to support the stronger causal inference, such as the use of negative controls, cross-contextual designs, and instrumental variable analysis ([@bib0130]). One type of instrumental variable analysis is Mendelian randomization (MR), in which genetic variants robustly are predicting an exposure of interest is used as an unconfounded proxy for that exposure. Therefore, any associations found between these genetic variants and the outcome provide evidence of a casual effect of the exposure captured by the genetic variants on the outcome, without the risk of reverse causation or confounding. Two-sample MR uses variant-exposure associations identified via genome-wide association studies (GWAS), and variant-outcome associations from another independent GWAS, using publicly-available summary data ([@bib0060]). The current study uses two-sample MR to examine the causal relationship between externalizing behaviors and tobacco initiation ([@bib0020]).To compare across the spectrum of externalizing disorders we used data available from both an aggression and an ADHD GWAS.

2. Methods {#sec0010}
==========

2.1. Exposure measures {#sec0015}
----------------------

For our externalizing behaviors exposure, we used summary data from the Early Life Epidemiology Consortium (EAGLE) consortium GWAS of aggressive behavior on a sample of 18,988 individuals. Aggression was measured using continuous study-specific scales ([@bib0265]). Six SNPs were identified as the top SNPs approaching genome-wide significance (P \< 5 × 10^−5^) for aggression. The GWAS further identified top SNPs stratified by age group, with five SNPs approaching genome-wide significance for early childhood (mean age 5.36 years, SD 1.5), and six SNPs for middle childhood/early adolescence (mean age 11.39 years, SD 1.86) (see Supplementary Table S1).

For our ADHD exposure, we used summary data from the Initiative for Integrative Psychiatric Research (iPSYCH) and Psychiatric Genomics Consortium (PGC) GWAS of ADHD on 55,354 individuals (ages 6--19) ([@bib0095]). ADHD was measured using the binary cohort-specific diagnosis of ADHD. Fourteen independent SNPs (were identified as genome-wide significant (P \< 5 × 10^−8^) (see Supplementary Table S2).

2.2. Outcome measures {#sec0020}
---------------------

For our tobacco initiation outcome, we used summary data from the Tobacco and Genetics Consortium (TAG) GWAS of smoking behavior ([@bib0310]). Tobacco initiation (n = 74,053) was a binary ever/never measure and age of initiation (n = 24,114) was the reported age at which participants started smoking.

2.3. Statistical analyses {#sec0025}
-------------------------

SNPs associated with aggression and ADHD were identified in their respective GWAS and subsequently extracted from the tobacco GWAS (see Supplementary Tables S1--S2). Where original SNPs were unavailable, proxy SNPs were identified using SNiPA (<http://snipa.helmholtz-muenchen.de/snipa3/>) with an r^2^ threshold of ≥0.9. SNP-exposure and SNP-outcome associations were combined using an inverse-variance weighted approach (IVW), weighted median approach, and MR-Egger regression. Here, we use multiple methods, each with differing underlying assumptions regarding instrument validity, to triangulate our results ([@bib0220]). IVW weights regression of SNP-exposure and SNP-outcome coefficients restricting the intercept to zero, and assumes all instruments are valid with no pleiotropy ([@bib0055]). Weighed median provides a causal estimate if at least 50% of the instruments are valid ([@bib0255]). MR-Egger uses an intercept coefficient in the weighted regression to relax the assumption that the outcome works strictly via the exposure (i.e., up to 100% of the instruments may be invalid). The intercept term displays the overall pleiotropic effect, while the slope (β) coefficient displays a causal estimate under the assumption the pleiotropic effects of the SNP on the outcome are unrelated to the associations between the SNP and exposure ([@bib0070]). Finally, I^2^ statistics were calculated to determine heterogeneity between estimates from multiple genetic instruments, with higher numbers indicating greater heterogeneity which could indicate potential violations of the MR assumptions. Main findings are presented as IVW within the text. To avoid inference based simply on P-value thresholds, the direction and strength of effect for each association, together with the corresponding P-value, is presented ([@bib0305]). All analyses were conducted in R (version 3.3.2). Additionally, there was no direct overlap between samples. However, it is possible some parents in the TAG may have offspring included in EAGLE.

3. Results {#sec0030}
==========

3.1. Aggression and tobacco initiation {#sec0035}
--------------------------------------

There was no clear evidence of an effect from the genetic risk of aggression to tobacco use initiation (β~IVW~\<0.001, 95% CI −0.003 to 0.002, P = 0.810). While the MR-Egger analysis suggested there is some evidence of an effect on initiation, the effect estimates were inconsistent with those from the IVW and weighted median analyses (see [Table 1](#tbl0005){ref-type="table"} for full results). Findings were similar when looking at the effect from the genetic risk of aggression to age at onset, with no clear evidence of an effect observed (β~IVW~\<0.001, 95% CI: 0.000--0.001, P = 0.125). These findings were consistent when restricted to early childhood and late adolescence (see [Table 1](#tbl0005){ref-type="table"}). There was moderate to high heterogeneity (see [Table 1](#tbl0005){ref-type="table"} for full results).Table 1Estimates of the causal effects of the risk of aggression behaviors on tobacco initiation and age of onset using IVW, MR-Egger and weighted median Mendelian randomization approaches.Table 1InitiationAge of onsetMethodβ95% CI*P* valueβ95% CI*P* value**Aggression (all ages, mean age = 8.4)**IVW0.000−0.003, 0.0020.8100.0000.000, 0.0010.125Weighted median0.001−0.003, 0.0020.7590.0000.000, 0.0010.161MR-Egger slope−0.039−0.056, −0.0210.0120.004−0.001, 0.0080.160MR-Egger intercept0.0190.170, 0.2040.012−0.017−0.038, 0.0040.188HeterogeneityI^2^ = 36%  **Aggression (early childhood, ages 3-7)**IVW−0.002−0.005, 0.0010.286−0.001−0.002, 0.0000.310Weighted median−0.003−0.008, 0.0030.3880.000−0.001, 0.0010.578MR-Egger slope−0.014−0.024, 0.0040.066−0.001−0.006, 0.0040.812MR-Egger intercept0.0320.007, 0.0580.0880.000−0.013, 0.0140.966HeterogeneityI^2^ = 82%  **Aggression (late adolescent, ages 8-15)**IVW−0.001−0.006, 0.0030.6100.0000.000, 0.0010.183Weighted median−0.001−0.006, 0.0030.5720.0000.000, 0.0010.292MR-Egger slope−0.016−0.005, 0.0250.0510.000−0.002, 0.0020.862MR-Egger intercept−0.069−0.113, −0.0250.0370.001−0.008, 0.0090.878HeterogeneityI^2^ = 93%

3.2. ADHD and tobacco initiation {#sec0040}
--------------------------------

There was weak evidence of an association from the genetic risk of ADHD to tobacco initiation (OR~IVW~ 1.23, 95% CI 1.10--1.35, P = 0.016), and low heterogeneity (I^2^  = 29%). Although MR-Egger analysis indicated that there was some evidence of pleiotropy (OR~Intercept~ 1.06, 95% CI 1.03--1.09, P = 0.020), the bias-adjusted effect estimate remained consistent with that estimated using the IVW approach and suggested some weak evidence of a causal effect (OR~Slope~ 1.40, 95% CI 1.10--1.78, P = 0.087). There was no clear evidence of an effect from the genetic risk of ADHD to the age of onset (see [Table 2](#tbl0010){ref-type="table"} for full results).Table 2Estimates of the causal effects of the risk of ADHD on tobacco initiation and age of onset using IVW, MR-Egger and weighted median Mendelian randomization approaches.Table 2InitiationAge of onsetMethodOR95% CI*P* valueOR95% CI*P* value**ADHD**IVW1.2301.110, 1.3500.0161.0220.992, 1.0520.215Weighted median1.180−1.033, 1.3270.0681.0140.947, 1.0810.705MR-Egger slope1.4401.101, 1.7790.0870.9280.797, 1.0590.315MR-Egger intercept1.060−1.027, 1.0930.0201.0040.997, 1.0110.202HeterogeneityI^2^ = 29%

3.3. Power calculation {#sec0045}
----------------------

Post-hoc power calculations were conducted for our IVW analyses using an online Mendelian randomization power calculation tool (<https://sb452.shinyapps.io/power/>) ([@bib0050]). For the analysis investigating the effect of aggression with tobacco use initiation, using a genetic instrument that explains 1% of the variation in aggression and a sample containing 28% smoking cases, our study has 77% power to detect a causal effect of β = 0.1. Power was similar when looking at the effect of aggression on age at onset. For the analysis investigating the effect of ADHD with tobacco use initiation, using a genetic instrument which explains 2% of the variation in ADHD and a sample containing 28% smoking cases, our study has 73% power to detect a causal effect of OR = 1.2. Power was similar when looking at the effect of ADHD on age at onset.

4. Discussion {#sec0050}
=============

Our results provide some evidence that genetic risk of childhood ADHD is causally related to increased risk of tobacco initiation; however, the causal estimate is relatively small. We found no clear evidence that genetic risk of childhood aggression is causally related to the risk of tobacco initiation or age of onset. Therefore, the observational evidence relating to these associations ([@bib0200]; [@bib0105]; [@bib0180]; [@bib0285]) may not be causal and may be due to environmental or confounding factors.

Our findings with respect to genetic risk of ADHD and tobacco use initiation correspond with observational evidence ([@bib0030]; [@bib0250]; [@bib0175]; [@bib0205]), and the converging evidence from different MR methodologies provides further confidence in these findings. Neurobiological evidence also supports these causal associations ([@bib0240]). However, as the MR-Egger analyses suggest some evidence of horizontal pleiotropy, the use of alternative causal inference methods relying on different assumptions (e.g. cross-contextual comparisons across populations where confounding structures differ) will allow triangulation to determine whether these results do reflect true causal relationships ([@bib0120]; [@bib0260]).

Within individuals with ADHD, a hypoactive striatal dopaminergic system produces increased dopamine transporter within corticostriatal circuits. This subsequently decreases dopamine tone and activation of presynaptic autoreceptors, resulting in exaggerated dopamine response to salient stimuli. As nicotine stimulates a response in the striatum of smokers, nicotine-stimulated phasic dopamine releases may be more rewarding for individuals with ADHD ([@bib0110]; [@bib0190], [@bib0195]; [@bib0145]). Therefore, this heightened reward response to dopamine in individuals with ADHD may be responsible for reward and maintenance effects ([@bib0185]; [@bib0145]).

These findings may help identify individuals particularly vulnerable to tobacco use behaviors, and therefore provide interventions from an early age. For example, previous evidence indicates that strong familial bonds and open communication within families and schools may serve as a protective factor, or help to delay adolescent substance initiation ([@bib0230]; [@bib0170]; [@bib0115]; [@bib0295]).

There are a number of important strengths to this study. The use of Mendelian randomization analysis strengthens causal inference and removes the possibility of reverse causation, confounding, and bias ([@bib0120], [@bib0125]). Furthermore, we integrated multiple methods with varying assumptions and strengths to formulate more robust causal inferences ([@bib0120]). The use of two-sample MR utilizes large sample sizes to provide the sufficient power required to detect small effects in complex phenotypes. However, there are also some limitations to consider. Unlike childhood aggression, which was a measurable trait of externalizing disorders, ADHD was only measured as a binary diagnosis. Previous evidence has suggested that particular traits of ADHD (i.e., inattention or impulsivity/hyperactivity) are more associated with the increased likelihood of tobacco initiation ([@bib0240]). However, the current GWAS only examined ADHD diagnosis and not by individual symptomology. A GWAS of these individual traits has been conducted in adulthood ([@bib0245]), but sample sizes were small, and summary statistics were unavailable. Finally, we conducted several analyses, which raises the possibility that some of the effects we report may represent false positives. This should be considered when interpreting our results as a whole.

Overall our results provided some evidence that there may be a causal association of genetic risk of ADHD on tobacco initiation, these results are in line with previous longitudinal and neurobiological evidence. However, there was no association between early aggressive behavior on tobacco initiation, suggesting these observed associations may be a result of additional variables. Our results suggest that prevention efforts should target these risk groups, and explore whether interventions to reduce these behaviors influence subsequent tobacco use initiation. By identifying at-risk individuals, prevention behaviors such as strengthening familial bonds, open communication within families and schools, and early intervention education may help delay or prevent adolescent substance use initiation. ([@bib0300]; [@bib0230]; [@bib0100]; [@bib0170]; [@bib0115]; [@bib0295]).
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